Previous studies have shown that GAS5 plays a regulatory role in the pathological process of a series of cardiovascular diseases such as hypertrophic cardiomyopathy [20] and myocardial infarction [21], yet its role in AF remains unclear. This evidence concerns the gene GAS5 and hypertrophic cardiomyopathy.